AstraZeneca announced that baxdrostat, a selective aldosterone synthase inhibitor, met its primary and all secondary endpoints in the BaxHTN Phase III trial, effectively lowering blood pressure ...

Baxdrostat meets primary and all secondary endpoints in BaxHTN phase III trial in patients with uncontrolled or treatment resistant hypertension: Cambridge, UK Wednesday, July 16, ...

AstraZeneca Plc (NASDAQ:AZN) released high-level results from the Cardiac Amyloid Reaching for Extended Survival (CARES) Phase 3 program. The trial showed that anselamimab, a light chain depleter ...

Amsterdam-listed shares in ASML (ASML.AS, ASML) slid more than 7% on Wednesday morning, after the chipmaking equipment supplier narrowed its guidance and offered a cautious outlook for 2026. In ...

The antibody anselamimab, which AstraZeneca picked up in its 2021 purchase of Caelum Biosciences, failed to improve survival and reduce hospitalizations, but the company sees promise in data from an ...

Tesla registered plans for a new six-seater Model Y L in China with a wheelbase of 3,040 mm, according to filing information published on China's industry ministry website on Wednesday. Tesla also ...

THE boss of the world's biggest Scotch whisky producer has stepped down from her role. Debra Crew, CEO of Diageo, is to leave the company following a two-year tenure. It comes as the spirits giant has ...